Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162300946> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2162300946 endingPage "3692" @default.
- W2162300946 startingPage "3682" @default.
- W2162300946 abstract "IL-6 is a cytokine synthesized by T cells and macrophages (M phi). It has pleiotropic effects on diverse cell types and is recognized for its pro-inflammatory properties. In mice, IL-4, IL-5, IL-6, and IL-10 are produced by Th-2 cells. Because IL-10 suppresses Th-1 clones, and IL-4 broadly deactivates M phi, experiments were carried out to investigate the in vitro effects of recombinant human IL-6 on cytokine activation of human M phi. Pretreatment with IL-6 induced a dose- and time-dependent suppression of IFN-gamma (1000 U/mL) and TNF-alpha (25 ng/mL) activation of M phi for the killing of L. amazonensis. At doses greater than 0.1 to 100 ng/mL, IL-6 inhibited IFN-gamma and TNF-alpha activation by 21 to 93% and 36 to 82%, respectively. IL-6 alone had no effect on M phi viability and intracellular L. amazonensis growth. Blockade of M phi activation was greatest when IL-6 was added 24 or 48 h before infection and treatment with IFN-gamma or TNF-alpha. Furthermore, mAb against IL-6 abrogated the inhibitory activity of IL-6. Similarly IL-6 pretreatment suppressed M phi activation for antileishmanial capacity by IL-3, granulocyte-monocyte-CSF (GM-CSF) and IL-1 beta. Because cytokine induction of antileishmanial activity is associated with enhancement of oxidative capacity, the effect of IL-6 on this mechanism was evaluated. Pretreatment with IL-6 down-modulated TNF-alpha (25 ng/mL) enhancement of M phi oxidative capacity in a dose- and time-dependent manner. A similar depression of oxidative capacity was observed for GM-CSF and IL-3 but not for IFN-gamma. Furthermore, NG-monomethyl-L-arginine (a nitric oxide synthase inhibitor) had no effect on IFN-gamma and TNF-alpha activation of antileishmanial activity and nitrites/nitrates were not reliably assayed from M phi culture supernatants. These findings suggest that IL-6 down-modulates cytokine activation of M phi antileishmanial capacity by inhibiting oxygen-dependent and undefined oxygen-independent mechanisms." @default.
- W2162300946 created "2016-06-24" @default.
- W2162300946 creator A5002101403 @default.
- W2162300946 creator A5018401693 @default.
- W2162300946 creator A5026386383 @default.
- W2162300946 creator A5026585270 @default.
- W2162300946 creator A5028607202 @default.
- W2162300946 creator A5078092707 @default.
- W2162300946 date "1993-10-01" @default.
- W2162300946 modified "2023-10-10" @default.
- W2162300946 title "IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages." @default.
- W2162300946 doi "https://doi.org/10.4049/jimmunol.151.7.3682" @default.
- W2162300946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8397259" @default.
- W2162300946 hasPublicationYear "1993" @default.
- W2162300946 type Work @default.
- W2162300946 sameAs 2162300946 @default.
- W2162300946 citedByCount "46" @default.
- W2162300946 countsByYear W21623009462012 @default.
- W2162300946 countsByYear W21623009462013 @default.
- W2162300946 countsByYear W21623009462014 @default.
- W2162300946 countsByYear W21623009462015 @default.
- W2162300946 countsByYear W21623009462016 @default.
- W2162300946 countsByYear W21623009462018 @default.
- W2162300946 countsByYear W21623009462021 @default.
- W2162300946 countsByYear W21623009462023 @default.
- W2162300946 crossrefType "journal-article" @default.
- W2162300946 hasAuthorship W2162300946A5002101403 @default.
- W2162300946 hasAuthorship W2162300946A5018401693 @default.
- W2162300946 hasAuthorship W2162300946A5026386383 @default.
- W2162300946 hasAuthorship W2162300946A5026585270 @default.
- W2162300946 hasAuthorship W2162300946A5028607202 @default.
- W2162300946 hasAuthorship W2162300946A5078092707 @default.
- W2162300946 hasBestOaLocation W21623009461 @default.
- W2162300946 hasConcept C153911025 @default.
- W2162300946 hasConcept C17991360 @default.
- W2162300946 hasConcept C185592680 @default.
- W2162300946 hasConcept C202751555 @default.
- W2162300946 hasConcept C203014093 @default.
- W2162300946 hasConcept C2778690821 @default.
- W2162300946 hasConcept C2781184567 @default.
- W2162300946 hasConcept C55493867 @default.
- W2162300946 hasConcept C86803240 @default.
- W2162300946 hasConcept C98274493 @default.
- W2162300946 hasConceptScore W2162300946C153911025 @default.
- W2162300946 hasConceptScore W2162300946C17991360 @default.
- W2162300946 hasConceptScore W2162300946C185592680 @default.
- W2162300946 hasConceptScore W2162300946C202751555 @default.
- W2162300946 hasConceptScore W2162300946C203014093 @default.
- W2162300946 hasConceptScore W2162300946C2778690821 @default.
- W2162300946 hasConceptScore W2162300946C2781184567 @default.
- W2162300946 hasConceptScore W2162300946C55493867 @default.
- W2162300946 hasConceptScore W2162300946C86803240 @default.
- W2162300946 hasConceptScore W2162300946C98274493 @default.
- W2162300946 hasIssue "7" @default.
- W2162300946 hasLocation W21623009461 @default.
- W2162300946 hasLocation W21623009462 @default.
- W2162300946 hasOpenAccess W2162300946 @default.
- W2162300946 hasPrimaryLocation W21623009461 @default.
- W2162300946 hasRelatedWork W133691617 @default.
- W2162300946 hasRelatedWork W1529226217 @default.
- W2162300946 hasRelatedWork W1994050787 @default.
- W2162300946 hasRelatedWork W2005546669 @default.
- W2162300946 hasRelatedWork W2059285926 @default.
- W2162300946 hasRelatedWork W2085322992 @default.
- W2162300946 hasRelatedWork W2097599259 @default.
- W2162300946 hasRelatedWork W2136418509 @default.
- W2162300946 hasRelatedWork W2136802530 @default.
- W2162300946 hasRelatedWork W2398878426 @default.
- W2162300946 hasVolume "151" @default.
- W2162300946 isParatext "false" @default.
- W2162300946 isRetracted "false" @default.
- W2162300946 magId "2162300946" @default.
- W2162300946 workType "article" @default.